English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 97 | Tables: 92 | Pharma & Healthcare
The global Alinia (nitazoxanide) market was valued at US$ 197 million in 2025 and is anticipated to reach US$ 247 million by 2032, at a CAGR of 3.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Alinia (nitazoxanide) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil). Nitazoxanide is used to treat diarrhea caused by Giardia or Cryptosporidium. These conditions are sometimes called "Traveler's diarrhea." Nitazoxanide is used in adults and children who are at least 1 year old.
The Alinia (nitazoxanide) market is primarily driven by the increasing prevalence of parasitic infections and gastrointestinal diseases worldwide. Nitazoxanide, a broad-spectrum anti-parasitic and anti-protozoal drug, is effective in treating infections like giardiasis, amebiasis, and other intestinal parasitic infections. The growing awareness of these diseases, especially in regions with poor sanitation and healthcare infrastructure, contributes to the demand for Alinia. Additionally, its effectiveness against a range of pathogens, including protozoa and some viral infections, positions it as a vital treatment option for physicians in endemic areas. As international health organizations push for better treatment solutions for neglected tropical diseases, the global need for Alinia continues to rise.
However, the Alinia market faces challenges related to its high cost and limited availability in certain regions. While nitazoxanide is effective, its price may be prohibitive for patients in low-income countries, where parasitic infections are most prevalent. This pricing issue is further compounded by competition from cheaper generic alternatives and the availability of other medications for similar conditions. Moreover, despite its broad-spectrum efficacy, Alinia’s usage is limited to specific conditions, and it is not always the first-line treatment, especially in more developed regions where other, more widely used drugs are available. Additionally, regulatory hurdles and approval processes in certain markets could hinder broader adoption, particularly in developing countries where access to essential medicines remains a challenge.
The key players of Alinia (nitazoxanide) include Romark Laboratories, Chugai Pharmaceutical, Lupin etc. The top three players of Alinia (nitazoxanide) account for approximately 45% of the total global market. Asia-Pacific is the largest consumer market of Alinia (nitazoxanide) accounting for about 45% followed by South America and Europe. In terms of Type, Tablets is the largest segment, with a share about 99%. And in terms of Application, the largest application is Hospital followed by Retail Pharmacy.
This report delivers a comprehensive overview of the global Alinia (nitazoxanide) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Alinia (nitazoxanide). The Alinia (nitazoxanide) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Alinia (nitazoxanide) market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Alinia (nitazoxanide) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Romark Laboratories
Chugai Pharmaceutical
Lupin
RISING
ZENARA
Segment by Type
Tablets
Oral Suspension
by Application
Retail Pharmacy
Hospital
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Alinia (nitazoxanide) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Alinia (nitazoxanide) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Alinia (nitazoxanide) Market Overview
1.1 Product Definition
1.2 Alinia (nitazoxanide) by Type
1.2.1 Global Alinia (nitazoxanide) Market Value by Type: 2025 vs 2032
1.2.2 Tablets
1.2.3 Oral Suspension
1.3 Alinia (nitazoxanide) by Application
1.3.1 Global Alinia (nitazoxanide) Market Value by Application: 2025 vs 2032
1.3.2 Retail Pharmacy
1.3.3 Hospital
1.3.4 Others
1.4 Global Alinia (nitazoxanide) Market Size Estimates and Forecasts
1.4.1 Global Alinia (nitazoxanide) Revenue 2021–2032
1.4.2 Global Alinia (nitazoxanide) Sales 2021–2032
1.4.3 Global Alinia (nitazoxanide) Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Alinia (nitazoxanide) Market Competition by Manufacturers
2.1 Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Alinia (nitazoxanide) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Alinia (nitazoxanide) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Alinia (nitazoxanide), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Alinia (nitazoxanide), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Alinia (nitazoxanide), Product Types and Applications
2.7 Global Key Manufacturers of Alinia (nitazoxanide), Date of Entry into the Industry
2.8 Global Alinia (nitazoxanide) Market Competitive Situation and Trends
2.8.1 Global Alinia (nitazoxanide) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Alinia (nitazoxanide) Players Market Share by Revenue
2.8.3 Global Alinia (nitazoxanide) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alinia (nitazoxanide) Market Scenario by Region
3.1 Global Alinia (nitazoxanide) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Alinia (nitazoxanide) Sales by Region: 2021–2032
3.2.1 Global Alinia (nitazoxanide) Sales by Region: 2021–2026
3.2.2 Global Alinia (nitazoxanide) Sales by Region: 2027–2032
3.3 Global Alinia (nitazoxanide) Revenue by Region: 2021–2032
3.3.1 Global Alinia (nitazoxanide) Revenue by Region: 2021–2026
3.3.2 Global Alinia (nitazoxanide) Revenue by Region: 2027–2032
3.4 North America Alinia (nitazoxanide) Market Facts & Figures by Country
3.4.1 North America Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Alinia (nitazoxanide) Sales by Country (2021–2032)
3.4.3 North America Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alinia (nitazoxanide) Market Facts & Figures by Country
3.5.1 Europe Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Alinia (nitazoxanide) Sales by Country (2021–2032)
3.5.3 Europe Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alinia (nitazoxanide) Market Facts & Figures by Region
3.6.1 Asia Pacific Alinia (nitazoxanide) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Alinia (nitazoxanide) Sales by Region (2021–2032)
3.6.3 Asia Pacific Alinia (nitazoxanide) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alinia (nitazoxanide) Market Facts & Figures by Country
3.7.1 Latin America Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Alinia (nitazoxanide) Sales by Country (2021–2032)
3.7.3 Latin America Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alinia (nitazoxanide) Market Facts & Figures by Country
3.8.1 Middle East and Africa Alinia (nitazoxanide) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Alinia (nitazoxanide) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Alinia (nitazoxanide) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alinia (nitazoxanide) Sales by Type (2021–2032)
4.1.1 Global Alinia (nitazoxanide) Sales by Type (2021–2026)
4.1.2 Global Alinia (nitazoxanide) Sales by Type (2027–2032)
4.1.3 Global Alinia (nitazoxanide) Sales Market Share by Type (2021–2032)
4.2 Global Alinia (nitazoxanide) Revenue by Type (2021–2032)
4.2.1 Global Alinia (nitazoxanide) Revenue by Type (2021–2026)
4.2.2 Global Alinia (nitazoxanide) Revenue by Type (2027–2032)
4.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Type (2021–2032)
4.3 Global Alinia (nitazoxanide) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Alinia (nitazoxanide) Sales by Application (2021–2032)
5.1.1 Global Alinia (nitazoxanide) Sales by Application (2021–2026)
5.1.2 Global Alinia (nitazoxanide) Sales by Application (2027–2032)
5.1.3 Global Alinia (nitazoxanide) Sales Market Share by Application (2021–2032)
5.2 Global Alinia (nitazoxanide) Revenue by Application (2021–2032)
5.2.1 Global Alinia (nitazoxanide) Revenue by Application (2021–2026)
5.2.2 Global Alinia (nitazoxanide) Revenue by Application (2027–2032)
5.2.3 Global Alinia (nitazoxanide) Revenue Market Share by Application (2021–2032)
5.3 Global Alinia (nitazoxanide) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Romark Laboratories
6.1.1 Romark Laboratories Company Information
6.1.2 Romark Laboratories Description and Business Overview
6.1.3 Romark Laboratories Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Romark Laboratories Alinia (nitazoxanide) Product Portfolio
6.1.5 Romark Laboratories Recent Developments/Updates
6.2 Chugai Pharmaceutical
6.2.1 Chugai Pharmaceutical Company Information
6.2.2 Chugai Pharmaceutical Description and Business Overview
6.2.3 Chugai Pharmaceutical Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Chugai Pharmaceutical Alinia (nitazoxanide) Product Portfolio
6.2.5 Chugai Pharmaceutical Recent Developments/Updates
6.3 Lupin
6.3.1 Lupin Company Information
6.3.2 Lupin Description and Business Overview
6.3.3 Lupin Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Lupin Alinia (nitazoxanide) Product Portfolio
6.3.5 Lupin Recent Developments/Updates
6.4 RISING
6.4.1 RISING Company Information
6.4.2 RISING Description and Business Overview
6.4.3 RISING Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 RISING Alinia (nitazoxanide) Product Portfolio
6.4.5 RISING Recent Developments/Updates
6.5 ZENARA
6.5.1 ZENARA Company Information
6.5.2 ZENARA Description and Business Overview
6.5.3 ZENARA Alinia (nitazoxanide) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 ZENARA Alinia (nitazoxanide) Product Portfolio
6.5.5 ZENARA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alinia (nitazoxanide) Industry Chain Analysis
7.2 Alinia (nitazoxanide) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alinia (nitazoxanide) Production Mode & Process Analysis
7.4 Alinia (nitazoxanide) Sales and Marketing
7.4.1 Alinia (nitazoxanide) Sales Channels
7.4.2 Alinia (nitazoxanide) Distributors
7.5 Alinia (nitazoxanide) Customer Analysis
8 Alinia (nitazoxanide) Market Dynamics
8.1 Alinia (nitazoxanide) Industry Trends
8.2 Alinia (nitazoxanide) Market Drivers
8.3 Alinia (nitazoxanide) Market Challenges
8.4 Alinia (nitazoxanide) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Alinia (nitazoxanide) Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Alinia (nitazoxanide) Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Alinia (nitazoxanide) Market Competitive Situation by Manufacturers in 2025
Table 4. Global Alinia (nitazoxanide) Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Alinia (nitazoxanide) Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Alinia (nitazoxanide) Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Alinia (nitazoxanide) Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Alinia (nitazoxanide) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Alinia (nitazoxanide), Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Alinia (nitazoxanide), Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Alinia (nitazoxanide), Product Types and Applications
Table 12. Global Key Manufacturers of Alinia (nitazoxanide), Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alinia (nitazoxanide) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Alinia (nitazoxanide) Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alinia (nitazoxanide) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Alinia (nitazoxanide) Sales by Region (K Units), 2021–2026
Table 18. Global Alinia (nitazoxanide) Sales Market Share by Region (2021–2026)
Table 19. Global Alinia (nitazoxanide) Sales by Region (K Units), 2027–2032
Table 20. Global Alinia (nitazoxanide) Sales Market Share by Region (2027–2032)
Table 21. Global Alinia (nitazoxanide) Revenue by Region (US$ Million), 2021–2026
Table 22. Global Alinia (nitazoxanide) Revenue Market Share by Region (2021–2026)
Table 23. Global Alinia (nitazoxanide) Revenue by Region (US$ Million), 2027–2032
Table 24. Global Alinia (nitazoxanide) Revenue Market Share by Region (2027–2032)
Table 25. North America Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
Table 27. North America Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
Table 28. North America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
Table 29. North America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
Table 32. Europe Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
Table 33. Europe Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Alinia (nitazoxanide) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Alinia (nitazoxanide) Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Alinia (nitazoxanide) Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Alinia (nitazoxanide) Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Alinia (nitazoxanide) Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
Table 42. Latin America Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
Table 43. Latin America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Alinia (nitazoxanide) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Alinia (nitazoxanide) Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Alinia (nitazoxanide) Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Alinia (nitazoxanide) Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Alinia (nitazoxanide) Revenue by Country (US$ Million), 2027–2032
Table 50. Global Alinia (nitazoxanide) Sales (K Units) by Type (2021–2026)
Table 51. Global Alinia (nitazoxanide) Sales (K Units) by Type (2027–2032)
Table 52. Global Alinia (nitazoxanide) Sales Market Share by Type (2021–2026)
Table 53. Global Alinia (nitazoxanide) Sales Market Share by Type (2027–2032)
Table 54. Global Alinia (nitazoxanide) Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Alinia (nitazoxanide) Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Alinia (nitazoxanide) Revenue Market Share by Type (2021–2026)
Table 57. Global Alinia (nitazoxanide) Revenue Market Share by Type (2027–2032)
Table 58. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2021–2026)
Table 59. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2027–2032)
Table 60. Global Alinia (nitazoxanide) Sales (K Units) by Application (2021–2026)
Table 61. Global Alinia (nitazoxanide) Sales (K Units) by Application (2027–2032)
Table 62. Global Alinia (nitazoxanide) Sales Market Share by Application (2021–2026)
Table 63. Global Alinia (nitazoxanide) Sales Market Share by Application (2027–2032)
Table 64. Global Alinia (nitazoxanide) Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Alinia (nitazoxanide) Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Alinia (nitazoxanide) Revenue Market Share by Application (2021–2026)
Table 67. Global Alinia (nitazoxanide) Revenue Market Share by Application (2027–2032)
Table 68. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2021–2026)
Table 69. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2027–2032)
Table 70. Romark Laboratories Company Information
Table 71. Romark Laboratories Description and Business Overview
Table 72. Romark Laboratories Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Romark Laboratories Alinia (nitazoxanide) Product
Table 74. Romark Laboratories Recent Developments/Updates
Table 75. Chugai Pharmaceutical Company Information
Table 76. Chugai Pharmaceutical Description and Business Overview
Table 77. Chugai Pharmaceutical Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Chugai Pharmaceutical Alinia (nitazoxanide) Product
Table 79. Chugai Pharmaceutical Recent Developments/Updates
Table 80. Lupin Company Information
Table 81. Lupin Description and Business Overview
Table 82. Lupin Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Lupin Alinia (nitazoxanide) Product
Table 84. Lupin Recent Developments/Updates
Table 85. RISING Company Information
Table 86. RISING Description and Business Overview
Table 87. RISING Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. RISING Alinia (nitazoxanide) Product
Table 89. RISING Recent Developments/Updates
Table 90. ZENARA Company Information
Table 91. ZENARA Description and Business Overview
Table 92. ZENARA Alinia (nitazoxanide) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. ZENARA Alinia (nitazoxanide) Product
Table 94. ZENARA Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Alinia (nitazoxanide) Distributors List
Table 98. Alinia (nitazoxanide) Customers List
Table 99. Alinia (nitazoxanide) Market Trends
Table 100. Alinia (nitazoxanide) Market Drivers
Table 101. Alinia (nitazoxanide) Market Challenges
Table 102. Alinia (nitazoxanide) Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Alinia (nitazoxanide)
Figure 2. Global Alinia (nitazoxanide) Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Alinia (nitazoxanide) Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Alinia (nitazoxanide) Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Alinia (nitazoxanide) Market Share by Application: 2025 & 2032
Figure 8. Retail Pharmacy
Figure 9. Hospital
Figure 10. Others
Figure 11. Global Alinia (nitazoxanide) Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Alinia (nitazoxanide) Market Size (US$ Million), 2021–2032
Figure 13. Global Alinia (nitazoxanide) Sales (K Units), 2021–2032
Figure 14. Global Alinia (nitazoxanide) Average Price (US$/Unit), 2021–2032
Figure 15. Alinia (nitazoxanide) Report Years Considered
Figure 16. Alinia (nitazoxanide) Sales Share by Manufacturers in 2025
Figure 17. Global Alinia (nitazoxanide) Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Alinia (nitazoxanide) Players: Market Share by Revenue in Alinia (nitazoxanide) in 2025
Figure 19. Alinia (nitazoxanide) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Alinia (nitazoxanide) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
Figure 22. North America Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
Figure 23. United States Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
Figure 26. Europe Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
Figure 27. Germany Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Alinia (nitazoxanide) Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Alinia (nitazoxanide) Revenue Market Share by Region (2021–2032)
Figure 34. China Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
Figure 44. Latin America Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Alinia (nitazoxanide) Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Alinia (nitazoxanide) Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Alinia (nitazoxanide) Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Alinia (nitazoxanide) by Type (2021–2032)
Figure 54. Global Revenue Market Share of Alinia (nitazoxanide) by Type (2021–2032)
Figure 55. Global Alinia (nitazoxanide) Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Alinia (nitazoxanide) by Application (2021–2032)
Figure 57. Global Revenue Market Share of Alinia (nitazoxanide) by Application (2021–2032)
Figure 58. Global Alinia (nitazoxanide) Price (US$/Unit) by Application (2021–2032)
Figure 59. Alinia (nitazoxanide) Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
